It is possible that this effect might be a result of the modulatory action of GH on the production of erythropoietin (EPO), as increased concentrations of GH augment the levels of EPO in GHD patients with developed anemia [27, 28], possibly due to increased hepatic synthesis of EPO [29]. This evidence concerns the gene GH1 and anemia.